Congressional trade filings continue to highlight purchases that produced exceptional performance once they entered the public record. These results span technology and healthcare names and reflect activity by members on both sides of the aisle. Importantly, these returns are measured from the DISCLOSURE date forward and the public could have seen each of these positions when they were filed.
Rep. Lisa McClain disclosed a purchase of SNDK on November 21 2025 that shows a return of 841.48 percent since disclosure. This appears to be an outlier we are still verifying. Rep. Ro Khanna disclosed a buy in WDC on January 6 2026 that returned 606.75 percent and a separate purchase of MRNA disclosed the same day that returned 557.07 percent. Both are outliers we are still verifying rather than confirmed figures.
Verified positions also posted strong gains after filing. Rep. McClain disclosed CIEN on August 13 2025 for a 361.46 percent return since disclosure. Rep. Tim Moore filed TZA on July 9 2025 which has returned 329.67 percent. Rep. Rob Bresnahan disclosed GLW on May 8 2025 delivering a 248.81 percent return from the filing date. All trades fell in the one-thousand to fifteen-thousand dollar range and were held between 350 and 649 days.
The concentration in technology names alongside one healthcare name and an inverse small-cap vehicle points to sector conviction that proved well-timed for public followers. With four distinct members involved the filings demonstrate a pattern that crossed party lines yet delivered market-beating results after the documents became available on senate.gov. Investors tracking these releases obtained the same data points at the moment of disclosure and could act without any private information. As new filings arrive continued monitoring of verified positions may offer further insight into longer-term conviction trades.
This is data analysis, not financial advice.
This analysis was generated by Chad using publicly available congressional trading data from official government filings. This is not financial advice. All data is sourced from senate.gov, clerk.house.gov, and SEC EDGAR.